Agarwal Shefali
SEC insider (Form 3/4/5 filer). CIK 0001746830. Director at FATE THERAPEUTICS INC (FATE) and 1 other issuer. 7 reported Form 4/5 transactions since Sep 2024; latest on Jun 12, 2026. Located in SAN DIEGO, CA.
Companies Agarwal Shefali has filed insider reports for
- FATE THERAPEUTICS INC (FATE): Director
- Gritstone bio, Inc. (GRTS): Director
Agarwal Shefali
CIK: 0001746830
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (7 total)
- Jun 12, 2026FATE
FATE THERAPEUTICS INC
AwardDirectStock Option (Right to Buy)
87.9K shares- - May 29, 2025FATE
FATE THERAPEUTICS INC
AwardDirectStock Option (Right to Buy)
55K shares- - Apr 4, 2025GRTS
Gritstone bio, Inc.
OtherDirectStock Option (Right to Buy)
51.8K shares- - Apr 4, 2025GRTS
Gritstone bio, Inc.
OtherDirectStock Option (Right to Buy)
937 shares- - Apr 4, 2025GRTS
Gritstone bio, Inc.
OtherDirectStock Option (Right to Buy)
19K shares- - Apr 4, 2025GRTS
Gritstone bio, Inc.
OtherDirectStock Option (Right to Buy)
38K shares- - Apr 4, 2025GRTS
Gritstone bio, Inc.
OtherDirectStock Option (Right to Buy)
51.8K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 12, 2026 |  FATE FATE THERAPEUTICS INC | Award Stock Option (Right to Buy) | 87,900 | - | - | Direct |
| May 29, 2025 | FATE FATE THERAPEUTICS INC | Award Stock Option (Right to Buy) | 55,000 | - | - | Direct |
| Apr 4, 2025 |  GRTS Gritstone bio, Inc. | Other Stock Option (Right to Buy) | 51,800 | - | - | Direct |
| Apr 4, 2025 | GRTS Gritstone bio, Inc. | Other Stock Option (Right to Buy) | 937 | - | - | Direct |
| Apr 4, 2025 | GRTS Gritstone bio, Inc. | Other Stock Option (Right to Buy) | 19,000 | - | - | Direct |
| Apr 4, 2025 | GRTS Gritstone bio, Inc. | Other Stock Option (Right to Buy) | 38,000 | - | - | Direct |
| Apr 4, 2025 | GRTS Gritstone bio, Inc. | Other Stock Option (Right to Buy) | 51,800 | - | - | Direct |
1-7 of 7 transactions